The Global Burden of Disease (GBD) study The Global Burden of Disease (GBD) study launched by the World Health Organizalaunched by the World Health Organization (WHO) in the 1990s aimed to provide tion (WHO) in the 1990s aimed to provide a set of summary measures that would be a set of summary measures that would be comprehensive and provide information comprehensive and provide information on disease and injury, including non-fatal on disease and injury, including non-fatal health outcomes, to inform global priority health outcomes, to inform global priority--setting for health research and to inform setting for health research and to inform international health policy and planning international health policy and planning (Murray & Lopez, 1996) . The study (Murray & Lopez, 1996) . The study showed that unipolar depressive disorders showed that unipolar depressive disorders place an enormous burden on society, and place an enormous burden on society, and ranked as the fourth leading cause of ranked as the fourth leading cause of burden among all diseases, burden among all diseases, accounting for accounting for 3.7% of total disability-adjusted life-years 3.7% of total disability-adjusted life-years (DALYs), and were one of the leading (DALYs), and were one of the leading causes of years lived with disability causes of years lived with disability 
METHOD METHOD
The three goals articulated for the GBD The three goals articulated for the GBD 1990 study remain central in the GBD 1990 study remain central in the GBD 2000 study. These are: to decouple epide-2000 study. These are: to decouple epidemiological assessment of the magnitude of miological assessment of the magnitude of health problems from advocacy by interest health problems from advocacy by interest groups favouring particular health policies groups favouring particular health policies or interventions; to include, in international or interventions; to include, in international health policy debates, information on nonhealth policy debates, information on nonfatal health outcomes along with inforfatal health outcomes along with information on mortality; and to undertake the mation on mortality; and to undertake the quantification of health problems into quantification of health problems into time-based units that can also be used in time-based units that can also be used in economic appraisal. economic appraisal.
A major focus of the GBD 2000 project A major focus of the GBD 2000 project was to improve the comparability, validity was to improve the comparability, validity and reliability of the descriptive epidemioland reliability of the descriptive epidemiology for mortality and non-fatal health ogy for mortality and non-fatal health outcomes attributed to various diseases, outcomes attributed to various diseases, injuries and risk factors. The GBD 2000 injuries and risk factors. The GBD 2000 working group identified the need to review working group identified the need to review the epidemiological estimates and disease the epidemiological estimates and disease models developed for neuropsychiatric dismodels developed for neuropsychiatric disorders that had been used in the original orders that had been used in the original GBD project's assessment of disability. As GBD project's assessment of disability. As a consequence of this review process, major a consequence of this review process, major changes have been made in the GBD 2000 changes have been made in the GBD 2000 study in the conceptualisation of depresstudy in the conceptualisation of depression, and new epidemiological estimates sion, and new epidemiological estimates have been used for estimating DALYs. have been used for estimating DALYs.
Case definition Case definition
The definitions of depressive episodes estabThe definitions of depressive episodes established by the ICD-10 were used (codes F 32, lished by the ICD-10 were used (codes F 32, F 33) (World Health Organization, 1992) . F 33) (World Health Organization, 1992) . Major depressive episodes as defined in Major depressive episodes as defined in DSM-IV (American Psychiatric Associa-DSM-IV (American Psychiatric Association, 1994 ) and DSM-III-R (American Psytion, 1994 ) and DSM-III-R (American Psychiatric Association, 1987) were considered chiatric Association, 1987) were considered alternative definitions, so that we would be alternative definitions, so that we would be able to use epidemiological data from surable to use epidemiological data from survey studies employing either of these two vey studies employing either of these two standard psychiatric classification systems. standard psychiatric classification systems.
Regions Regions
For geographic disaggregation of the GBD For geographic disaggregation of the GBD 2000, the six WHO regions of the world 2000, the six WHO regions of the world (i.e. Africa, Americas, Eastern Mediterra-(i.e. Africa, Americas, Eastern Mediterranean, Europe, South-East Asia, Western nean, Europe, South-East Asia, Western Pacific) were further divided into 17 epiPacific) were further divided into 17 epidemiological subregions, based on levels demiological subregions, based on levels of child (under 5 years) and adult (15-59 of child (under 5 years) and adult (15-59 years) mortality for WHO member states. years) mortality for WHO member states. Five mortality strata were defined in terms Five mortality strata were defined in terms of quintiles of the distribution of child of quintiles of the distribution of child and adult mortality (both genders comand adult mortality (both genders combined). When these mortality strata are bined). When these mortality strata are applied to the six WHO regions, they proapplied to the six WHO regions, they produce 14 mortality subregions. For the purduce 14 mortality subregions. For the purposes of burden of disease epidemiological poses of burden of disease epidemiological analyses, two of these regions were further analyses, two of these regions were further subdivided: EurB into EurB1 and EurB2, subdivided: EurB into EurB1 and EurB2, the latter including the central Asian states; the latter including the central Asian states; and WprB into WprB1 (mainly China), and WprB into WprB1 (mainly China), WprB2 (South-East Asian countries) and WprB2 (South-East Asian countries) and WprB3 (Pacific Islands). Additionally, some WprB3 (Pacific Islands). Additionally, some member states have been reclassified into member states have been reclassified into subregions with similar epidemiological/ subregions with similar epidemiological/ geographical/ethnic patterns in order to geographical/ethnic patterns in order to maximise the epidemiological homogeneity maximise the epidemiological homogeneity of the subregions for the purposes of epiof the subregions for the purposes of epidemiological analysis. A detailed Years of life lost to mortality Years of life lost to mortality due to depression due to depression
The first analytical step in the GBD 2000 The first analytical step in the GBD 2000 study was to estimate the age-specific death study was to estimate the age-specific death 3 8 6 3 8 6 
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Episode duration Episode duration
The GBD 2000 study assumes a 6-month The GBD 2000 study assumes a 6-month duration for episodes of depression. This duration for episodes of depression. This figure is based on recent studies and is configure is based on recent studies and is consistent with classical descriptions from the sistent with classical descriptions from the pre-antidepressant era. The same duration pre-antidepressant era. The same duration was used in GBD 1990 and the US Burden was used in GBD 1990 and the US Burden of Disease Study. The length of depressive of Disease Study. The length of depressive episodes has been the subject of many inepisodes has been the subject of many investigations, most of which were carried vestigations, most of which were carried out with inadequate methodologies. The out with inadequate methodologies. The duration of episodes had a log-normal disduration of episodes had a log-normal distribution; therefore, the best way to report tribution; therefore, the best way to report this variable is in terms of logarithmic this variable is in terms of logarithmic values or non-parametric parameters, such values or non-parametric parameters, such as medians and quartiles. However, in the as medians and quartiles. However, in the GBD project, the arithmetic mean has been GBD project, the arithmetic mean has been used for the estimation of the YLD across used for the estimation of the YLD across all the conditions. Therefore, an effort all the conditions. Therefore, an effort was required to obtain information on was required to obtain information on duration of depressive episodes reported duration of depressive episodes reported as an arithmetic mean, to be consistent with as an arithmetic mean, to be consistent with the methods in the GBD project. the methods in the GBD project.
Data gathered as part of more recent Data gathered as part of more recent epidemiological studies were re-analysed epidemiological studies were re-analysed to establish the mean duration of episodes to establish the mean duration of episodes in subjects with depression in the comin subjects with depression in the community. The first study was the Baltimore munity. The first study was the Baltimore Epidemiologic Catchment Area Follow-up Epidemiologic Catchment Area Follow-up (Eaton (Eaton et al et al, 1989 ). In 1981 , 3481 residents , 1989 . In 1981, 3481 residents of Baltimore, from a probabilistic sample of of Baltimore, from a probabilistic sample of 4238 residents, completed a psychiatric 4238 residents, completed a psychiatric evaluation with the National Institute of evaluation with the National Institute of Mental Health Diagnostic Interview ScheMental Health Diagnostic Interview Schedule (DIS). In 1993, these 3481 people were dule (DIS). In 1993, these 3481 people were targeted for follow-up and interviewed targeted for follow-up and interviewed again with the DIS. A specific analysis of again with the DIS. A specific analysis of this database was conducted to obtain estithis database was conducted to obtain estimates for the different parameters of the mates for the different parameters of the epidemiologic queuing formula: P epidemiologic queuing formula: P¼I I6 6D, D, where P is the point prevalence, I is the inwhere P is the point prevalence, I is the incidence density and D is the mean duration cidence density and D is the mean duration of episodes. A total of 1725 respondents of episodes. A total of 1725 respondents were interviewed and 536 episodes of dewere interviewed and 536 episodes of depression were evaluated. The mean durapression were evaluated. The mean duration of episodes in weeks was 26.57 for tion of episodes in weeks was 26.57 for both genders (male both genders (male¼25.7; female 25.7; female¼26.85). 26.85). The second psychiatric database that The second psychiatric database that was analysed to obtain estimates of the was analysed to obtain estimates of the duration of episodes was the National duration of episodes was the National Comorbidity Survey (Kessler Comorbidity Survey (Kessler et al et al, 1994) . , 1994). This survey did not include a longitudinal This survey did not include a longitudinal follow-up of cases identified in the follow-up of cases identified in the community, but the diagnostic interview community, but the diagnostic interview included questions related to the duration included questions related to the duration of lifetime episodes of DSM-III-R depresof lifetime episodes of DSM-III-R depression. For the purpose of this analysis, 3% sion. For the purpose of this analysis, 3% of the subjects were excluded for having of the subjects were excluded for having especially long durations. For the remaining especially long durations. For the remaining 97% of the sample with episodes of depres-97% of the sample with episodes of depression, the overall mean duration was 22.6 sion, the overall mean duration was 22.6 weeks (Ustun & Kessler, 2002) . weeks (Ü stü n & Kessler, 2002) .
Finally, the NEMESIS study, a major Finally, the NEMESIS study, a major epidemiological survey carried out in a epidemiological survey carried out in a national representative sample from The national representative sample from The Netherlands, was also used to address the Netherlands, was also used to address the question of episode duration. This was a question of episode duration. This was a prospective study on the prevalence of psyprospective study on the prevalence of psychiatric disorders in the Dutch population chiatric disorders in the Dutch population aged 18-64. A total of 7076 people were aged 18-64. A total of 7076 people were interviewed personally in 1996 with the interviewed personally in 1996 with the Composite International Diagnostic InterComposite International Diagnostic Interview (CIDI), and re-interviewed later as view (CIDI), and re-interviewed later as part of an incidence study. The survival part of an incidence study. The survival analysis of the 250 persons with newly analysis of the 250 persons with newly originated episodes during the follow-up originated episodes during the follow-up period found a mean duration of 8.4 period found a mean duration of 8.4 months (Spijker months (Spijker et al et al, 2002) . , 2002).
Prevalence estimates Prevalence estimates
We completed a systematic review of all We completed a systematic review of all available published and non-published paavailable published and non-published papers of meaningful population studies on pers of meaningful population studies on depressive disorders in order to create the depressive disorders in order to create the most up-to-date data-set on the epidemiolmost up-to-date data-set on the epidemiology of depressive disorders. Criteria for ogy of depressive disorders. Criteria for studies to be included in this review were studies to be included in this review were as follows: as follows:
(a) (a) population-based studies (with sample population-based studies (with sample sizes of sizes of n n4 41000); 1000); (b) (b) studies that reported prevalence (wherstudies that reported prevalence (wherever possible, with a specification of ever possible, with a specification of the period covered: 2 weeks; 1 month; the period covered: 2 weeks; 1 month; 6 months; 12 months; and lifetime); 6 months; 12 months; and lifetime); whenever possible, these data were whenever possible, these data were converted into point prevalence; converted into point prevalence;
(c) (c) studies that reported incidence, preferstudies that reported incidence, preferably with specific age and gender distriably with specific age and gender distribution; from these studies data were bution; from these studies data were regrouped into the eight age groups, regrouped into the eight age groups, as follows: 0-4; 5-14; 15-29; 30-44; as follows: 0-4; 5-14; 15-29; 30-44; 45-59; 60-69; 70-79; 80+ years (this 45-59; 60-69; 70-79 ; 80+ years (this was expanded from the original five was expanded from the original five age groups used in the GBD 1990); age groups used in the GBD 1990);
(d) (d) studies using a clearly specified method studies using a clearly specified method for sampling (a design that would yield for sampling (a design that would yield a probabilistic national/regional reprea probabilistic national/regional representative sample) and implementation. sentative sample) and implementation.
3 8 7 3 8 7 
World population World population 6 045 170 000 6 045 170 000 3 045 370 000 3 045 370 000 2 999 800 000 2 999 800 000 This was a household survey carried out with was a household survey carried out with the objective of assessing health states, disthe objective of assessing health states, disability and provision of health services ability and provision of health services in nationally representative samples in nationally representative samples ( (n n¼5000-10 000) of adults living in rural 5000-10 000) of adults living in rural and urban areas of different WHO and urban areas of different WHO regions: China, Colombia, Egypt, Georgia, regions: China, Colombia, Egypt, Georgia, India, Indonesia, Mexico, Nigeria, the India, Indonesia, Mexico, Nigeria, the Slovak Republic and Turkey. Where no Slovak Republic and Turkey. Where no data for a region were available, experts data for a region were available, experts on psychiatric epidemiology were enon psychiatric epidemiology were encouraged to make informed estimates. couraged to make informed estimates.
Frequently, age patterns of incidence and Frequently, age patterns of incidence and prevalence were based on the assumption prevalence were based on the assumption that some regions have similar epidemiothat some regions have similar epidemiological patterns but might differ in the level logical patterns but might differ in the level of incidence or prevalence. In the worst of incidence or prevalence. In the worst cases, where no information whatsoever cases, where no information whatsoever was available, estimates were based excluwas available, estimates were based exclusively on data or information from other sively on data or information from other regions. Table 2 presents a summary of regions. Table 2 presents a summary of the data sources and assumptions regarding the data sources and assumptions regarding the estimates for depressive disorders for all the estimates for depressive disorders for all the WHO regions used in the burden calcuthe WHO regions used in the burden calculations. Table 3 features age-standardised lations. Table 3 features age-standardised prevalence rate estimates for depressive prevalence rate estimates for depressive episodes in the WHO epidemiological subepisodes in the WHO epidemiological subregions. Comorbidity is common with psyregions. Comorbidity is common with psychiatric conditions, especially between chiatric conditions, especially between anxiety and depressive disorders. For coanxiety and depressive disorders. For comorbidity between depression and anxiety morbidity between depression and anxiety disorders, comorbid states were attributed disorders, comorbid states were attributed to the depressive illness -more severe of to the depressive illness -more severe of the two conditions in terms of the disability the two conditions in terms of the disability weight assigned to the condition. The GBD weight assigned to the condition. The GBD estimates of anxiety disorder prevalence, estimates of anxiety disorder prevalence, incidence and severity, therefore, reflect incidence and severity, therefore, reflect no comorbidity with depression. This no comorbidity with depression. This approach translates to lower burden approach translates to lower burden estimates for anxiety disorders. estimates for anxiety disorders.
Incidence estimates Incidence estimates
For the epidemiology of depression, the For the epidemiology of depression, the primary sources of information are crossprimary sources of information are crosssectional population prevalence surveys. sectional population prevalence surveys. Incidence rates need to be estimated based Incidence rates need to be estimated based on these observed prevalence rates. Other on these observed prevalence rates. Other sources of information, such as small-scale sources of information, such as small-scale follow-up studies, could be useful in follow-up studies, could be useful in suggesting a credible range of incidence. suggesting a credible range of incidence.
3 8 8 3 8 8 In GBD 2000, incidence estimates for In GBD 2000, incidence estimates for depressive episodes were derived from depressive episodes were derived from prevalence and duration with the epiprevalence and duration with the epidemiologic queuing formula P demiologic queuing formula P¼I I6 6D. The D. The incidence estimates of depressive episodes incidence estimates of depressive episodes used are presented in Table 3 , broken used are presented in Table 3 , broken down by gender. We compared these theodown by gender. We compared these theoretical incidence estimates with the pubretical incidence estimates with the published results of the few studies that lished results of the few studies that provide data on the incidence of depressive provide data on the incidence of depressive disorders in community samples. Murphy disorders in community samples. Murphy (2000) reviewed this issue and found an (2000) reviewed this issue and found an interval effect which has a major impact interval effect which has a major impact on the final incidence figures found in on the final incidence figures found in follow-up studies. Short-interval studies, follow-up studies. Short-interval studies, such as the Epidemiologic Catchment Area such as the Epidemiologic Catchment Area follow-up study (Eaton follow-up study (Eaton et al et al, 1989) , , 1989), found lower annual incidence rates than found lower annual incidence rates than the long-interval studies, such as the the long-interval studies, such as the Stirling County study (Murphy, 2000) . We Stirling County study (Murphy, 2000) . We considered it more appropriate to use considered it more appropriate to use short-interval studies in order to check the short-interval studies in order to check the consistency of our epidemiological esticonsistency of our epidemiological estimates. The incidence figure of depressive mates. The incidence figure of depressive episodes will be closer to the incidence episodes will be closer to the incidence of depressive disorder obtained in shortof depressive disorder obtained in shortinterval studies than that obtained in longinterval studies than that obtained in longinterval studies. interval studies.
Disability weights and severity Disability weights and severity breakdown breakdown
The YLD estimates of the GBD 2000 are The YLD estimates of the GBD 2000 are based largely on the GBD 1990 disability based largely on the GBD 1990 disability weights or on the Dutch disability weights weights or on the Dutch disability weights (Stouthard (Stouthard et al et al, 1997) . Three different , 1997). Three different severity levels of depressive episodes have severity levels of depressive episodes have been considered in the disease model used been considered in the disease model used for the estimation of the burden of depresfor the estimation of the burden of depression: mild, moderate and severe, with a sion: mild, moderate and severe, with a disability weight of 0.14, 0.35 and 0.76, disability weight of 0.14, 0.35 and 0.76, respectively. respectively.
RESULTS RESULTS
Depressive disorders were estimated to be Depressive disorders were estimated to be the leading cause of disability (i.e. non-fatal the leading cause of disability (i.e. non-fatal burden) in the world in 1990, accounting burden) in the world in 1990, accounting for 10.7% of total YLD. Correspondingly, for 10.7% of total YLD. Correspondingly, these disorders were the fourth leading these disorders were the fourth leading cause of total global burden of disease, accause of total global burden of disease, accounting for 3.7% of total DALYs (Murray counting for 3.7% of total DALYs (Murray & Lopez, 1996) . A decade later, according & Lopez, 1996) . A decade later, according to these revised estimates for the GBD 2000 to these revised estimates for the GBD 2000 study (World Health Organization, 2002) , study (World Health Organization, 2002) , unipolar depressive disorders remain one unipolar depressive disorders remain one of the leading causes of total DALYs worldof the leading causes of total DALYs worldwide (Table 4 ). Globally, they account for wide (Table 4 ). Globally, they account for 4.46% of total DALYs and for 12.1% of 4.46% of total DALYs and for 12.1% of total YLDs. Perinatal conditions, lower retotal YLDs. Perinatal conditions, lower respiratory infections, HIV/AIDS and unipospiratory infections, HIV/AIDS and unipolar depressive disorders are the four lar depressive disorders are the four leading causes of DALYs for men and leading causes of DALYs for men and women combined. The total DALYs for women combined. The total DALYs for perinatal conditions, lower respiratory perinatal conditions, lower respiratory infections and HIV/AIDS are similar in infections and HIV/AIDS are similar in magnitude for men and women. A more magnitude for men and women. A more important gender difference is for depresimportant gender difference is for depression, which is the fourth leading cause of sion, which is the fourth leading cause of disease burden in women but ranks seventh disease burden in women but ranks seventh for men (5.6% for men (5.6% v v. 3.4% of total DALYs, . 3.4% of total DALYs, respectively). Detailed tables for deaths, respectively). Detailed tables for deaths, YLLs, YLDs and DALYs by subregion, YLLs, YLDs and DALYs by subregion, cause, gender and age group can also be cause, gender and age group can also be downloaded from the WHO website at downloaded from the WHO website at http://www.who.int/evidence/bod. http://www.who.int/evidence/bod.
There is a marked contrast in the epideThere is a marked contrast in the epidemiological patterns between rich and poor miological patterns between rich and poor regions of the world. Thus, in the more regions of the world. Thus, in the more developed countries, the share of disease developed countries, the share of disease burden from communicable, maternal, burden from communicable, maternal, perinatal and nutritional conditions is typiperinatal and nutritional conditions is typically around 5%, compared with 70-75% cally around 5%, compared with 70-75% in Africa. The contribution of depression in Africa. The contribution of depression to the total disease burden in Africa in to the total disease burden in Africa in 2000 was 1.2%, ranking in 13th position; 2000 was 1.2%, ranking in 13th position; in the Americas it was the leading cause, in the Americas it was the leading cause, representing 8% of the total burden. Overrepresenting 8% of the total burden. Overall, in high-income countries the burden of all, in high-income countries the burden of depressive disorders was 8.9%, whereas in depressive disorders was 8.9%, whereas in middle-and low-income countries the middle-and low-income countries the burden was 4.1% of the total DALYs. burden was 4.1% of the total DALYs.
DISCUSSION DISCUSSION
The present paper has summarised the The present paper has summarised the methods and data sources used for the esti- 
Comparison of GBD 1990
Comparison of GBD 1990 and GBD 2000 and GBD 2000
The original Global Burden of Disease The original Global Burden of Disease study, GBD 1990, highlighted the public study, GBD 1990, highlighted the public health significance of depressive disorders, health significance of depressive disorders, providing the tool for comparative assessproviding the tool for comparative assessment in a general health context. However, ment in a general health context. However, in assessing the burden of depressive in assessing the burden of depressive disorders, the GBD 1990 study had disorders, the GBD 1990 study had certain shortfalls that GBD 2000 tried to certain shortfalls that GBD 2000 tried to overcome. The first was that the overcome. The first was that the epidemiological data used as input for the epidemiological data used as input for the original GBD study to calculate the burden original GBD study to calculate the burden due to depressive disorders remain debatadue to depressive disorders remain debatable: episode incidence was modelled as 29 ble: episode incidence was modelled as 29 per 100 000 per year for women, and 16 per 100 000 per year for women, and 16 per 100 000 per year for men. Average per 100 000 per year for men. Average age at onset was taken as 37.1 years and age at onset was taken as 37.1 years and the average episode duration was considthe average episode duration was considered to be 6 months (Murray & Lopez, ered to be 6 months (Murray & Lopez, 1996) . These incidence estimates are very 1996). These incidence estimates are very low in comparison with the recent findings low in comparison with the recent findings from epidemiological surveys. In addition, from epidemiological surveys. In addition, depression is now known to occur in depression is now known to occur in younger age groups, often between 20 younger age groups, often between 20 and 25 years, as compared with the estiand 25 years, as compared with the estimate of 37.1 used in the GBD analysis. mate of 37.1 used in the GBD analysis. This, in fact, means that the degrees of This, in fact, means that the degrees of burden estimated from the GBD results burden estimated from the GBD results were actually underestimates for depreswere actually underestimates for depressive disorders. Moreover, the GBD study sive disorders. Moreover, the GBD study considered depression as only an adult considered depression as only an adult disease. There is overwhelming evidence disease. There is overwhelming evidence at present that depression occurs with at present that depression occurs with considerable frequency in childhood and considerable frequency in childhood and adolescence (Costello adolescence (Costello et al et al, 1996) . In the , 1996). In the GBD 2000 the incidence estimates used GBD 2000 the incidence estimates used were higher (49 per 100 000 per year for were higher (49 per 100 000 per year for women and 31 per 100 000 per year for women and 31 per 100 000 per year for men) and with incident cases of depressive men) and with incident cases of depressive episodes appearing at younger ages, than episodes appearing at younger ages, than in the GBD 1990. Finally, in the GBD in the GBD 1990. Finally, in the GBD 1990 study, the disability weight for 1990 study, the disability weight for depressive disorder was taken as 0.6 for depressive disorder was taken as 0.6 for untreated cases, irrespective of severity of untreated cases, irrespective of severity of depression (i.e. mild, moderate or severe). depression (i.e. mild, moderate or severe). However, it is evident that various levels However, it is evident that various levels of illness severity are associated with of illness severity are associated with different degrees of disability. Different different degrees of disability. Different disability weights were assigned for the disability weights were assigned for the different levels of severity in the GBD different levels of severity in the GBD 2000. 2000.
Limitations Limitations
There are varying degrees of uncertainty in There are varying degrees of uncertainty in GBD 2000 estimates for depressive disor-GBD 2000 estimates for depressive disorders, reflecting uncertainty in the prevaders, reflecting uncertainty in the prevalence of depression in different regions of lence of depression in different regions of the world and uncertainty in the variation the world and uncertainty in the variation of their severity distribution. Despite of their severity distribution. Despite intense efforts to obtain information on intense efforts to obtain information on prevalence estimates of this frequent condiprevalence estimates of this frequent condition in all the WHO regions, there are still tion in all the WHO regions, there are still extensive and highly populated areas of the extensive and highly populated areas of the world where the epidemiology of depresworld where the epidemiology of depression is largely unknown because of a lack sion is largely unknown because of a lack of data. There is a tendency in descriptive of data. There is a tendency in descriptive epidemiology to refuse to make estimates epidemiology to refuse to make estimates where data are sparse, uncertain or based where data are sparse, uncertain or based on studies that do not reach certain methon studies that do not reach certain methodological standards. To the contrary, odological standards. To the contrary, disciplines such as demography and ecodisciplines such as demography and economics often aim to make the best possible nomics often aim to make the best possible estimates using any available data, employestimates using any available data, employing a range of techniques, depending on the ing a range of techniques, depending on the type and quality of evidence. Thus, the type and quality of evidence. Thus, the GBD 1990 has been criticised by some epi-GBD 1990 has been criticised by some epidemiologists for using 'estimates' rather demiologists for using 'estimates' rather than 'actual data'. This is not a relevant disthan 'actual data'. This is not a relevant discussion for comparative burden estimates cussion for comparative burden estimates because all epidemiological data relating because all epidemiological data relating to population are 'estimates' of varying to population are 'estimates' of varying degrees of precision or uncertainty. The degrees of precision or uncertainty. The 3 9 0 3 9 0 The WHO has initiated the World Mental Health Surveys, which will implement tal Health Surveys, which will implement and analyse general population epidemioloand analyse general population epidemiological surveys of mental, substance use and gical surveys of mental, substance use and behavioural disorders in at least 18 counbehavioural disorders in at least 18 countries throughout all WHO regions. This intries throughout all WHO regions. This initiative will yield needed epidemiological itiative will yield needed epidemiological parameters for many regions of the world parameters for many regions of the world and will improve the accuracy of the prevaand will improve the accuracy of the prevalence and incidence figures used for the lence and incidence figures used for the estimation of the burden of depressive estimation of the burden of depressive disorders in the future. disorders in the future.
Depression as a public health Depression as a public health priority priority
The fact that depressive disorders rank The fact that depressive disorders rank fourth as a source of DALYs, even though fourth as a source of DALYs, even though they cause few deaths, underscores how asthey cause few deaths, underscores how assessment of both fatal and non-fatal health sessment of both fatal and non-fatal health outcomes affects the ranking of disease buroutcomes affects the ranking of disease burden. Until recently, counting deaths was the den. Until recently, counting deaths was the only way to determine the priorities for only way to determine the priorities for public health actions and to control public health actions and to control whether public health programmes were whether public health programmes were succeeding. Mental disorders have never succeeding. Mental disorders have never been ranked on the top 10 priority list of been ranked on the top 10 priority list of public health significance when mortality public health significance when mortality indicators alone were used. Once the morindicators alone were used. Once the mortality and disability effects of disease were tality and disability effects of disease were combined into a single metric, such as the combined into a single metric, such as the DALYs, the magnitude of the burden of DALYs, the magnitude of the burden of mental disorders in general, and of depresmental disorders in general, and of depression in particular, became apparent. With sion in particular, became apparent. With this new approach, depressive disorders this new approach, depressive disorders are properly classified as being priority are properly classified as being priority health problems. This high burden is a health problems. This high burden is a result of a combination of a high prevalence result of a combination of a high prevalence of depression, high impact on functioning of depression, high impact on functioning and early age of onset. and early age of onset.
The importance of depression worldThe importance of depression worldwide was one of the key findings of the wide was one of the key findings of the original Global Burden of Disease study, original Global Burden of Disease study, which has been confirmed for the analysis which has been confirmed for the analysis of the year 2000. The results of the GBD of the year 2000. The results of the GBD 2000 study have shown variations by 2000 study have shown variations by regions, but patterns and trends are remarkregions, but patterns and trends are remarkably similar worldwide. Depressive disably similar worldwide. Depressive disorders constitute a large proportion in the orders constitute a large proportion in the global burden of disease, both in the develglobal burden of disease, both in the developed and developing countries. oped and developing countries.
The Global Burden of Disease results The Global Burden of Disease results have attracted the attention of policy have attracted the attention of policy makers and public health experts alike, makers and public health experts alike, because they provide a common metric for because they provide a common metric for evaluating and priority-setting across a evaluating and priority-setting across a wide range of health problems. DALYs, wide range of health problems. DALYs, being based on a universal measure of time, being based on a universal measure of time, life-years, provide a trans-professional curlife-years, provide a trans-professional currency to determine priorities for health rency to determine priorities for health and human services and to evaluate their and human services and to evaluate their effectiveness. effectiveness.
There is a strong interest among policy There is a strong interest among policy makers to monitor the impact of health care makers to monitor the impact of health care reforms and other interventions, using a reforms and other interventions, using a common cost-effectiveness measure. The common cost-effectiveness measure. The appeal of the DALY measure is that it proappeal of the DALY measure is that it provides a potentially useful tool for health vides a potentially useful tool for health policy purposes: the transformation of policy purposes: the transformation of epidemiological data into informed deciepidemiological data into informed decisions about resource allocation for health sions about resource allocation for health care. DALYs can be used in different ways. care. DALYs can be used in different ways. They can be used to set priorities for service They can be used to set priorities for service provision, as an outcome measure to provision, as an outcome measure to monitor/evaluate performance of services monitor/evaluate performance of services in terms of consumer outcomes and to in terms of consumer outcomes and to compare cost-effectiveness of different compare cost-effectiveness of different interventions. interventions.
These results of the Global Burden of These results of the Global Burden of Disease study have provided the most Disease study have provided the most powerful scientific and advocacy support powerful scientific and advocacy support for mental health to date. It is now time for mental health to date. It is now time to see how these findings and these tools to see how these findings and these tools can be applied to policy-making, planning can be applied to policy-making, planning and programme implementation. and programme implementation. ity (principal investigator, T. B. Ustun, National Instiity (principal investigator, T. B. U « stu« n, National Institutes of Health Grant UOIMH35883) and WHO's tutes of Health Grant UOIMH35883) and WHO's Global Programme on Evidence for Health Policy. Global Programme on Evidence for Health Policy. To reduce the burden, effective strategies need to be found to shorten episode duration and prevent recurrence in at-risk populations. duration and prevent recurrence in at-risk populations.
& & Because of the high burden of depression worldwide, there is a need to integrate Because of the high burden of depression worldwide, there is a need to integrate its treatment into primary care services and treat mental disorders with parity in its treatment into primary care services and treat mental disorders with parity in health systems and in coverage in insurance schemes. health systems and in coverage in insurance schemes.
LIMITATIONS LIMITATIONS
& & Underreporting in official statistics of deaths related to mental disorders, in Underreporting in official statistics of deaths related to mental disorders, in general, and depression in particular. general, and depression in particular.
& & Uncertainty of prevalence and incidence estimates.
Uncertainty of prevalence and incidence estimates.
